Treatment of Risperidone-Associated Hyperprolactinemia With Aripiprazole

J Clin Psychopharmacol. 2018 Oct;38(5):529-531. doi: 10.1097/JCP.0000000000000942.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adolescent
  • Antipsychotic Agents / adverse effects
  • Antipsychotic Agents / therapeutic use
  • Aripiprazole / therapeutic use*
  • Female
  • Humans
  • Hyperprolactinemia / chemically induced*
  • Hyperprolactinemia / drug therapy*
  • Risperidone / adverse effects*

Substances

  • Antipsychotic Agents
  • Aripiprazole
  • Risperidone